Inventory of the most in the global pharmaceutical field in 2019

Pencil lead The financial statements of the world's leading pharmaceutical companies in 2019 have been disclosed in succession, and the sales volume of the world's heavyweight drugs in 2019 gradually surfaced So who's the top 10 best selling drugs in the world? In addition to maintaining the stable sales of listed drugs, new drug research and development is a strategic direction of sustainable and healthy development of major pharmaceutical companies around the world So what "latest" blockbuster innovative drugs will be successfully launched in 2019? Behind the endless heavy weight of innovative drugs, it is the tireless efforts of the world's major innovative drug companies So what are the "strongest" innovative biopharmaceutical companies in the world? In 2019, the sales volume of three drugs has exceeded 10 billion US dollars, and there are two more drugs of 10 billion class compared with 2018 There have also been new changes in the ranking of the top 10 drugs in the world In terms of the top three over 10 billion, xiumeile still ranks first, and has been the "king of medicine" for eight consecutive years However, its sales peak is now, and sales in 2019 are slightly lower than that in 2018 For the first time, coreda and Rimage are among the 10 billion US dollars Among them, k-drug ranked third in 2018 has a strong growth By 2019, its sales volume has surpassed that of Rimage, ranking second on the list It has set a new record of breaking 10 billion US dollars in five years of listing, and may create more records in the future Starting from the fourth place, the sales volume is densely distributed, and the phenomenon of "dragon fights tiger" is obvious Ibtinib of Johnson and Aberdeen leaped up 6 places to the fourth place, while o-drug of BMS rose 3 places to the fifth place, while Enron and Pfizer's etanercept and Roche's rituximab dropped 4 places to the ninth and 10th respectively More Than This Recently, Nature Reviews Drug Discovery released top product forecasts for In 2020, the top ten drugs in the world in 2020 are predicted: (1) this prediction confirms that K medicine will continue to grow at a high speed in the future, and will continue to approach sumerial; (2) the sales of O medicine is much less than k medicine; (3) the growth of elotal, which is jointly developed by BMS and Pfizer, is also relatively strong, leaping to the fourth place, but its compound patent will expire in September 2022, and hausen, Zhengda Tianqing Coelen's generic drugs have been approved in succession, and it is estimated that it will be difficult to avoid the volume purchase at that time, which will have a great impact on the sales of elotor; (4) ibudinib or zebudinib, the best in class drug in Baiji, has been affected by the listing, falling to No 8; (5) Roche's avidin, melowa and Amgen and Pfizer's etanercept have not been included in the list Figure 1 overview of the top 10 best selling drugs in the world Source: financial statements of all companies, top product forecasts for 2020, Zhongkang Industrial Capital Research Center In 2019, a number of heavyweight innovative drugs will be launched in the world From the field of treatment, cancer is still the focus of the direction Specifically, Novartis was approved with three drugs, respectively, for sclerosing disease, spinal muscular atrophy and breast cancer; Roche was approved with two drugs, respectively, for lymphoma and various solid tumors; Johnson & Johnson was also approved with two drugs, respectively, for depression and urothelial cancer; Alberta was approved with one drug for psoriasis; zebutini in Baiji Shenzhou was used for the treatment of cell lymphoid sheath Cancer, and achieved a new Chinese cancer drug to sea zero breakthrough From the perspective of the countries of approval agencies, the top ten heavyweight new drugs are distributed in Japan, the United States and the European Union The U.S region has the most listing, with 9 heavyweight new drugs; the European Union has 2, and Japan has 1 The heavyweight new drug for psoriasis was launched in the United States, the European Union and Japan in the same year Figure 2: top ten new drugs on the market in 2019 Source: Zhongkang Industrial Capital Research Center Recently, Biospace released a list of the top 10 most innovative biomedical companies in the world in 2019 The assessment is based on the results of its 2019 Life Sciences ideal employer report From the list, there are not only the world's top international pharmaceutical giants, such as Novartis, but also the specific departments of pharmaceutical giants, such as verily, and the rising stars in the international pharmaceutical field From the countries on the list: seven of the 10 pharmaceutical companies are headquartered in the United States, which once again confirms the strong R & D strength of the United States in the world; in addition, Germany, Switzerland and the United Kingdom each have a pharmaceutical company on the list Figure 3 top 10 most innovative biopharmaceutical companies in 2019 Source: who are the 10 most innovative biopharma companies?, Zhongkang Industrial Capital Research Center reference: